Condition: Pancreatic Cancer · Microbiome · Sponsor: Herlev Hospital
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
This description comes directly from the study's public registry record.
Bojan Kovacevic, ph.d., MD · 0045 3868 6312 · bojan.kovacevic@regionh.dk
Louise Maegaard, MSc, RN · 90045 3868 9879 · louise.maegaard@regionh.dk
Always discuss trial participation with your own doctor first.
| Herlev og Gentofte Hospital | Herlev, Capital Region, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07250100